glp-1 news today 2025 obesity drug october GLP-1 Agonists Weight Loss Drugs Market Size Report, 2030 How Employers Can Manage GLP-1

Carefully selected blend of premium ingredients works synergistically t

Online Journal | Justin Plank | January 2025 Background Every year, the United States spends an estimated $173 billion treating obesity-related diseases like diabetes and heart disease, more than the annual budgets of 42 U.S

Here's what clinicians should know.

Pendulum, a research-based health company, has launched a groundbreaking new product - a probiotic supplement designed to naturally suppress appetite

The plaintiffs allege that drugmaker Novo Nordisk didn't warn them about the risks of taking the medication

This powerful synbiotic blend supports healthy digestion by promoting regularity and improving nutrient absorption